Banque Pictet & Cie’s SOPHiA GENETICS SOPH Stock Holding History
Bought
Maintained
Sold
Other funds holding SOPH
GIM
ACM
AWA
HCM
BPCE
LCM
EDRH
RG
QC
Banque Pictet & Cie's SOPH Position: Q2 2026 in Review
Banque Pictet & Cie held its SOPHiA GENETICS (SOPH) position steady in Q2 2026 at 2,208,280 shares worth $12.7M. The position accounts for 0.08% of the portfolio, ranked #90.
Banque Pictet & Cie first reported a position in SOPH in Q1 2022 and has held it in 18 quarters since. The position peaked at $16.2M in Q1 2022. 28 funds tracked by Wall St. Rank hold SOPH as of Q2 2026.
- Banque Pictet & Cie held 2,208,280 shares of SOPHiA GENETICS worth $12.7M as of Q2 2026.
- Banque Pictet & Cie left its SOPHiA GENETICS share count unchanged in Q2 2026.
- SOPHiA GENETICS made up 0.08% of Banque Pictet & Cie's portfolio in Q2 2026, its #90 holding.
- Banque Pictet & Cie first reported a position in SOPHiA GENETICS in Q1 2022 and has held it in 18 quarters since.
- Banque Pictet & Cie's SOPHiA GENETICS position peaked at $16.2M in Q1 2022.
- 28 funds tracked by Wall St. Rank held SOPHiA GENETICS as of Q2 2026.
Based on Banque Pictet & Cie's 13F filing for Q2 2026, filed 24 Jul 2026.